Randomized Phase III Trial to Test Accelerated Versus Standard Fractionation in Combination With Concurrent Cisplatin for Head and Neck Carcinomas in the Radiation Therapy Oncology Group 0129 Trial: Long-Term Report of Efficacy and Toxicity

PURPOSE: We tested the efficacy and toxicity of cisplatin plus accelerated fractionation with a concomitant boost (AFX-C) versus standard fractionation (SFX) in locally advanced head and neck carcinoma (LA-HNC). PATIENTS AND METHODS: Patients had stage III to IV carcinoma of the oral cavity, orophar...

Full description

Saved in:
Bibliographic Details
Published in:J Clin Oncol
Main Authors: Nguyen-Tan, Phuc Felix, Zhang, Qiang, Ang, K. Kian, Weber, Randal S., Rosenthal, David I., Soulieres, Denis, Kim, Harold, Silverman, Craig, Raben, Adam, Galloway, Thomas J., Fortin, André, Gore, Elizabeth, Westra, William H., Chung, Christine H., Jordan, Richard C., Gillison, Maura L., List, Marcie, Le, Quynh-Thu
Format: Artigo
Language:Inglês
Published: American Society of Clinical Oncology 2014
Subjects:
ORIGINAL REPORTS
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC4239304/
https://ncbi.nlm.nih.gov/pubmed/25366680
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2014.55.3925
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items